Eagle Bay Advisors’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-202
Closed -$60.6K 482
2024
Q4
$60.6K Buy
202
+5
+3% +$1.75K 0.04% 308
2024
Q3
$80.1K Hold
197
0.03% 352
2024
Q2
$63.3K Hold
197
0.04% 303
2024
Q1
$65.7K Hold
197
0.04% 273
2023
Q4
$53.3K Hold
197
0.03% 286
2023
Q3
$48.5K Hold
197
0.02% 417
2023
Q2
$59.8K Sell
197
-13
-6% -$3.61K 0.03% 336
2023
Q1
$55.4K Hold
210
0.03% 360
2022
Q4
$50.4K Hold
210
0.03% 374
2022
Q3
$39K Buy
210
+76
+57% +$15.1K 0.02% 395
2022
Q2
$22.5K Buy
+134
New +$28.8K 0.01% 535
2022
Q1
Sell
-90
Closed -$23K 581
2021
Q4
$23K Sell
90
-22
-20% -$5.38K 0.01% 537
2021
Q3
$27K Sell
112
-99
-47% -$24.2K 0.02% 544
2021
Q2
$46K Buy
+211
New +$43K 0.04% 357

Other funds holding HCA

Eagle Bay Advisors's HCA Position: Q1 2025 in Review

Eagle Bay Advisors sold out of HCA Healthcare (HCA) in Q1 2025, closing a stake of 202 shares — an estimated $60.6K sold.

Eagle Bay Advisors first reported a position in HCA in Q2 2021 and held it in 14 quarters. The position peaked at $80.1K in Q3 2024. 1,224 funds tracked by Wall St. Rank hold HCA as of Q1 2025.

  • Eagle Bay Advisors reported no remaining HCA Healthcare position as of Q1 2025 after selling out during the quarter.
  • Eagle Bay Advisors sold 202 HCA Healthcare shares in Q1 2025, an estimated $60.6K.
  • Eagle Bay Advisors first reported a position in HCA Healthcare in Q2 2021 and held it in 14 quarters.
  • Eagle Bay Advisors's HCA Healthcare position peaked at $80.1K in Q3 2024.
  • 1,224 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2025.

Based on Eagle Bay Advisors's 13F filing for Q1 2025, filed 5 May 2025.